9 results match your criteria: "90134Royal Melbourne Hospital[Affiliation]"
Australas Psychiatry
December 2022
Hand-n-Hand Peer Support, Melbourne, Australia; 3917Tasmanian Health Service, Hobart, TAS, Australia; and University of Tasmania, Hobart, TAS, Australia.
Introduction: Founded at the beginning of the COVID-19 pandemic, Hand-n-Hand Peer Support (HnH) offers free, confidential peer support to healthcare workers (HCWs) across Australia and New Zealand. This survey aimed to evaluate HCWs experiences of peer support and collect demographic data about what groups of HCWs were seeking support.
Methods: An online survey was conducted in November 2021 of HCWs who were either active or past HnH participants ( = 158).
Australas Psychiatry
April 2022
Allied Health, 90134Royal Melbourne Hospital, Parkville, VIC, Australia.
Objective: This longitudinal study examined changes in psychological outcomes of perioperative frontline healthcare workers at one of Australia's most COVID-19 affected hospitals, following the surge and decline of a pandemic wave.
Method: A single-centred longitudinal online survey was conducted between 26 May and 17 November 2020. Recruitment was via poster advertisement and email invitation.
Australas Psychiatry
August 2022
Monash Alfred Psychiatry Research Centre, 22457The Alfred and Monash University Central Clinical School, Melbourne, Australia.
Purpose: This study aims to assess the reliability and construct validity of the City Birth Trauma Scale (BiTS) in Oceania and confirm the latent factor structure of postpartum posttraumatic stress disorder (PTSD).
Methods: Participants completed the City BiTS, demographic and obstetric information via an online survey. Psychometric properties of the City BiTS were investigated using confirmatory factor analyses (CFA).
Clin Rehabil
April 2022
Department of Physiotherapy, 90134Royal Melbourne Hospital, Melbourne, VIC, Australia.
Objective: To investigate the feasibility and preliminary efficacy of a group self-management exercise and education program in people with multiple sclerosis.
Design: Feasibility randomised controlled trial.
Setting: Outpatient rehabilitation facility.
Am J Hosp Palliat Care
February 2022
Department of Respiratory and Sleep Medicine, 90134The Royal Melbourne Hospital, Parkville, Victoria, Australia.
Objectives: Interstitial lung disease (ILD) is a debilitating and life-limiting condition, requiring multi-disciplinary care. While guidelines recommend early specialist palliative care referral to improve symptoms and quality of life, few patients access such care towards the end-of-life. This study aimed to explore clinicians' perspectives regarding specialist palliative care and opioids to understand barriers to optimal care and guide clinical practice improvement initiatives.
View Article and Find Full Text PDFAm J Hosp Palliat Care
May 2021
Department of Respiratory and Sleep Medicine, 90134The Royal Melbourne Hospital, Parkville, Victoria, Australia.
Context: Patients with advanced chronic obstructive pulmonary disease (COPD) can develop increasing breathlessness, which can persist despite optimal medical management-refractory breathlessness. Management can be challenging for all clinicians and requires a broad approach that includes optimization of disease directed therapies, non-pharmacological strategies to manage breathlessness and for some patients opioids.
Objectives: To explore the approaches to breathlessness management and palliative care undertaken by Australian General Practitioners (GP) for patients with severe COPD and refractory breathlessness.
Vasc Endovascular Surg
November 2020
Department of Surgery, 22457Monash University, Clayton, Victoria, Australia.
Am J Hosp Palliat Care
February 2021
Department of Respiratory and Sleep Medicine, 3805Austin Health, Heidelberg, Victoria, Australia.
Background: Fibrotic interstitial lung diseases (f-ILDs) are often progressive and incurable. As patients experience significant symptoms and have a poor prognosis, early palliative care referral is recommended.
Objective: To examine the care delivered to patients with f-ILD during the terminal hospital admission and the past 2 years of life.
Int J Stroke
June 2021
Stroke & Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health, 2541Monash University, Clayton, VIC, Australia.
Background: The Melbourne Mobile Stroke Unit (MSU) is the first Australian service to provide prehospital acute stroke treatment, including thrombolysis and facilitated triage for endovascular thrombectomy.
Aims: To estimate the cost-effectiveness of the MSU during the first full year of operation compared with standard ambulance and hospital stroke care pathways (standard care).
Methods: The costs and benefits of the Melbourne MSU were estimated using an economic simulation model.